Literature DB >> 14645465

The management of motor neurone disease.

P N Leigh1, S Abrahams, A Al-Chalabi, M-A Ampong, L H Goldstein, J Johnson, R Lyall, J Moxham, N Mustfa, A Rio, C Shaw, E Willey.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14645465      PMCID： PMC1765641          DOI： 10.1136/jnnp.74.suppl_4.iv32

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  63 in total

1.  External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis.

Authors:  P M Andersen; H Grönberg; L Franzen; U Funegård
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

2.  A prospective study of quality of life in ALS patients treated with noninvasive ventilation.

Authors:  R A Lyall; N Donaldson; T Fleming; C Wood; I Newsom-Davis; M I Polkey; P N Leigh; J Moxham
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

3.  Respiratory muscle assessment in motor neurone disease.

Authors:  N Mustfa; J Moxham
Journal:  QJM       Date:  2001-09

4.  Quality of life in ALS depends on factors other than strength and physical function.

Authors:  Z Simmons; B A Bremer; R A Robbins; S M Walsh; S Fischer
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

5.  Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders.

Authors:  D Stefanutti; M R Benoist; P Scheinmann; M Chaussain; J W Fitting
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 6.  Improving the quality of life for people with ALS: the challenge ahead.

Authors:  H Mitsumoto; M Del Bene
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

7.  Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis.

Authors:  J C Desport; P M Preux; L Magy; Y Boirie; J M Vallat; B Beaufrère; P Couratier
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

8.  Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis.

Authors:  I Arnulf; T Similowski; F Salachas; L Garma; S Mehiri; V Attali; V Behin-Bellhesen; V Meininger; J P Derenne
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

9.  The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study.

Authors:  I C Newsom-Davis; R A Lyall; P N Leigh; J Moxham; L H Goldstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

10.  Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.

Authors:  R A Lyall; N Donaldson; M I Polkey; P N Leigh; J Moxham
Journal:  Brain       Date:  2001-10       Impact factor: 13.501
View more
  39 in total

Review 1.  The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Authors:  F Agosta; A Chiò; M Cosottini; N De Stefano; A Falini; M Mascalchi; M A Rocca; V Silani; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

2.  ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy.

Authors:  Stefano Zoccolella; Ettore Beghi; Guerrino Palagano; Angela Fraddosio; Vito Guerra; Vito Lepore; Isabella Laura Simone; Paolo Lamberti; Luigi Serlenga; Giancarlo Logroscino
Journal:  J Neurol       Date:  2007-04-13       Impact factor: 4.849

3.  Management of symptoms in amyotrophic lateral sclerosis.

Authors:  Lisa S Thibodeaux; Amparo Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

Review 4.  Diagnostic investigation and multidisciplinary management in motor neuron disease.

Authors:  J A Rocha; C Reis; F Simões; J Fonseca; J Mendes Ribeiro
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

Review 5.  Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.

Authors:  Alan Moore; Carolyn A Young; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

Review 6.  Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Authors:  Stefanie M A Willekens; Donatienne Van Weehaeghe; Philip Van Damme; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-08       Impact factor: 9.236

7.  Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.

Authors:  Carsten W Lederer; Antonietta Torrisi; Maria Pantelidou; Niovi Santama; Sebastiano Cavallaro
Journal:  BMC Genomics       Date:  2007-01-23       Impact factor: 3.969

8.  Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Authors:  Peter M Andersen; Magdalena Kuzma-Kozakiewicz; Jürgen Keller; Helena E A Aho-Oezhan; Katarzyna Ciecwierska; Natalia Szejko; Cynthia Vázquez; Sarah Böhm; Gisela Badura-Lotter; Thomas Meyer; Susanne Petri; Katharina Linse; Andreas Hermann; Olof Semb; Erica Stenberg; Simona Nackberg; Johannes Dorst; Ingo Uttner; Ann-Cristin Häggström; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2018-05-04       Impact factor: 4.849

Review 9.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

10.  Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency.

Authors:  Pierluigi Carratù; Lucia Spicuzza; Anna Cassano; Mauro Maniscalco; Felice Gadaleta; Donato Lacedonia; Cristina Scoditti; Ester Boniello; Giuseppe Di Maria; Onofrio Resta
Journal:  Orphanet J Rare Dis       Date:  2009-03-10       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.